Skip to content

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients: Feasibility Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03480555
Acronym
Replenish
Enrollment
40
Registered
2018-03-29
Start date
2018-05-16
Completion date
2019-09-10
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, ARDS, Septic Shock, Multiple Trauma, Seizure Disorder, Hemorrhagic Shock

Keywords

Enteral nutrition, Intensive Care Units, caloric restriction, insulin, mortality, protein catabolism

Brief summary

In this study, we will explore the feasibility of a randomized controlled trial that will compare high protein dose from ICU day 6 to 14 with moderate protein intake.

Detailed description

Patients will be recruited on day 1-2 of ICU admission. On day 5, patients will be randomized into one of the two intervention arms; Replenish Protein group: Patients randomized to this group will receive 2 g of protein/kg/day (acceptable range 1.8 - 2.2 g of protein/kg/day) for day 6-14. Standard Protein group: Patients randomized to this group will receive protein at 0.8 - 1.0 g of protein/kg/day for day 6-14

Interventions

DIETARY_SUPPLEMENTReplenish Protein

Subjects randomized to this group will receive 2 g of protein/kg/day (acceptable range as 1.8 - 2.2 g of protein/kg/day) for day 6-14.

DIETARY_SUPPLEMENTStandard protein

Subjects randomized to this group will receive 0.8 - 1 g of protein/kg/day for day 6-14

Sponsors

King Abdullah International Medical Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years 2. Mechanically ventilated 3. Receiving enteral feeding via nasogastric/orogastric or duodenal or PEG or jejunostomy tubes and 4. Expected to stay ≥ 1 week in the ICU

Exclusion criteria

1. Lack of commitment to ongoing life support, which includes; * Terminal Illness (Malignancy or irreversible condition with 6 month mortality \> 50%) * DNR order in the first 48 hours and brain death within 48 hours of admission) (Don't include the presence of a Do Not Resuscitate order alone, if there is a commitment to ongoing life support). 2. Patients not fed within 48 hours of admission 3. Patients on total parenteral nutrition (TPN) 4. Patients being fed orally 5. Chronic renal failure 6. Chronic liver disease 7. Renal replacement therapy 8. Pregnancy. 9. Kidney transplant 10. Post-liver transplant. 11. Post cardiac arrest. 12. Burn patients. 13. Prisoners Screened patients will be screened again for eligibility at day 5, should be mechanically ventilated and expected to stay ≥ 3 days in the ICU. At this point, patients will be excluded if they meet the following; 1. New onset renal replacement therapy. 2. Acute Kidney Injury (serum creatinine \> 3 times the preacute level or serum creatinine \>350mmol/L with a recent increase of \>44 mmols/L) 3. Significant liver impairment

Design outcomes

Primary

MeasureTime frameDescription
Recruitment6 monthsRecruitment log
Retention rate14 dayswithdrawals
Achieved protein intake14 daysFeeding data

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026